Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer-Reference-Cited by-同舟云学术

Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Published:2018-04-20 Issue:30 Volume:9 Page:21444-21458
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Avivar-Valderas Alvaro¹²,McEwen Robert¹,Taheri-Ghahfarokhi Amir³,Carnevalli Larissa S.⁴,Hardaker Elizabeth L.⁴,Maresca Marcello³,Hudson Kevin⁴⁵,Harrington Elizabeth A.¹,Cruzalegui Francisco¹⁶

Affiliation:

1. Translational Science, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK

2. Current address: TiGenix, Parque Tecnológico de Madrid, Tres Cantos, Madrid, Spain

3. Translational Genomics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

4. Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK

5. Current address: 2TheNth, Adelphi Mill, Bollington, Macclesfield, UK

6. Current address: Pierre Fabre R&D Centre, Toulouse, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status;Breast Cancer;2024-06-13

2. BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients;ACS Omega;2024-04-03

3. Precision Genome Editing: The Synergy of CRISPR and Nanotechnology in Cancer Treatment;Current Cancer Therapy Reviews;2024-03-26

4. MAP3K1 Identified as a Prognostic Biomarker in Breast Cancer After Multi-omics Bioinformatics Analysis;2023-12-20

5. PhenoDriver: interpretable framework for studying personalized phenotype-associated driver genes in breast cancer;Briefings in Bioinformatics;2023-08-09